TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Soflin Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,798
|
8,261
|
8,162 |
Financial expenses |
78
|
458
|
219 |
Earnings before taxes |
1,913
|
1,460
|
1,511 |
EBITDA |
2,092
|
1,955
|
1,762 |
Total assets |
6,273
|
4,123
|
4,452 |
Current assets |
3,719
|
2,720
|
2,453 |
Current liabilities |
2,491
|
1,101
|
2,039 |
Equity capital |
3,388
|
2,633
|
2,123 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.0%
|
63.9%
|
47.7% |
Turnover per employee |
4,899
|
4,130
|
4,081 |
Profit as a percentage of turnover |
19.5%
|
17.7%
|
18.5% |
Return on assets (ROA) |
31.7%
|
46.5%
|
38.9% |
Current ratio |
149.3%
|
247.0%
|
120.3% |
Return on equity (ROE) |
56.5%
|
55.5%
|
71.2% |
Change turnover |
951
|
344
|
957 |
Change turnover % |
11%
|
4%
|
13% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.